A Prospective Cohort Study of Patients Undergoing ALND for Treatment of Breast Cancer: The Efficacy of a Comprehensive Prevention Program in Decreasing the Incidence of Lymphedema and Improving Quality of Life
Status: Recruiting
Location: See all (7) locations...
Intervention Type: Other, Diagnostic test, Procedure
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Female sex
• Diagnosis of breast cancer
• Ages 18 to 75 years
• Consented for unilateral ALND or for unilateral SLNB with possible ALND
Locations
United States
New Jersey
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
RECRUITING
Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
RECRUITING
Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
RECRUITING
Montvale
New York
Memorial Sloan Kettering Commack (Limited Protocol Activities)
RECRUITING
Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
RECRUITING
Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITING
New York
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
RECRUITING
Uniondale
Contact Information
Primary
Michelle Coriddi, MD
coriddim@mskcc.org
646-608-8042
Backup
Babak Mahrara, MD
mehrarab@MSKCC.ORG
646-608-8085
Time Frame
Start Date: 2023-11-16
Estimated Completion Date: 2030-03-16
Participants
Target number of participants: 285
Treatments
Experimental: Participants with Breast Cancer
Participants will have a diagnosis of breast cancer and may undergo axillary lymph node dissection.
Related Therapeutic Areas
Sponsors
Leads: Memorial Sloan Kettering Cancer Center